Eif4g2tm1b(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Eif4g2tm1b(KOMP)Wtsi |
Name: |
eukaryotic translation initiation factor 4, gamma 2; targeted mutation 1b, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5498138 |
Gene: |
Eif4g2 Location: Chr7:110667192-110682237 bp, - strand Genetic Position: Chr7, 58.0 cM
|
Alliance: |
Eif4g2tm1b(KOMP)Wtsi page
|
IMPC: |
Eif4g2 gene page |
|
Mutant Cell Line: |
EPD0322_4_E10 |
Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
Parent Cell Line: |
JM8A1.N3 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 110678215 of Chromosome 7 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of the targeted exon(s) at position 110679920. The critical exon(s) were thus flanked by loxP sites, and seubsequent cre-mediated excision removed the critical exon and neomycin selection cassette yielding a reporter knockout allele. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:148605, J:173534, J:188991)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:188991 The Jackson Laboratory, Alleles produced for the KOMP project by The Jackson Laboratory. MGI Direct Data Submission. 2012; |
All: |
6 reference(s) |
|